Myriad Genetics Inc
Research Myriad Genetics Inc (MYGN) on Bullrun: market cap USD 552.52M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMYGN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 552.52M
- Financial periodFY2025
- RevenueUSD 824.50M
- Revenue growth-1.6%
- Net income-USD 366.00M
- Gross margin69.9%
Valuation Snapshot
latest market cap is USD 552.52M.
About Myriad Genetics Inc
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers;
Frequently asked questions
What is Myriad Genetics Inc's market cap?
Myriad Genetics Inc's market capitalization is USD 552.52M.
What does Myriad Genetics Inc do?
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers;